Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism
Nadja Ehmke; Kristina Cusmano-Ozog; Rainer Koenig; Manuel Holtgrewe; Banu Nur; Ercan Mihci; Holly Babcock; Claudia Gonzaga-Jauregui; John D. Overton; Jing Xiao; Ariel F. Martinez; Maximilian Muenke; Alexander Balzer; Judith Jochim; Naji El Choubassi; Björn Fischer-Zirnsak; Céline Huber; Uwe Kornak; Sarah H. Elsea; Valérie Cormier-Daire; Carlos R. Ferreira
Published: April, 2020
Abstract
Catel-Manzke syndrome is characterized by the combination of Pierre Robin sequence and radial deviation, shortening as well as clinodactyly of the index fingers, due to an accessory ossification center. Mutations in TGDS have been identified as one cause of Catel-Manzke syndrome, but cannot be found as causative in every patient with the clinical diagnosis. We performed a chromosome microarray and/or exome sequencing in three patients with hand hyperphalangism, heart defect, short stature, and mild to severe developmental delay, all of whom were initially given a clinical diagnosis of Catel-Manzke syndrome. In one patient, we detected a large deletion of exons 1–8 and the missense variant c.1282C > T (p.Arg428Trp) in KYNU (NM_003937.2), whereas homozygous missense variants in KYNU were found in the other two patients (c.989G > A (p.Arg330Gln) and c.326G > C (p.Trp109Ser)). Plasma and urine metabolomic analysis of two patients indicated a block along the tryptophan catabolic pathway and urine organic acid analysis showed excretion of xanthurenic acid. Biallelic loss-of-function mutations in KYNU were recently described as a cause of NAD deficiency with vertebral, cardiac, renal and limb defects; however, no hand hyperphalangism was described in those patients, and Catel-Manzke syndrome was not discussed as a differential diagnosis. In conclusion, we present unrelated patients identified with biallelic variants in KYNU leading to kynureninase deficiency and xanthurenic aciduria as a very likely cause of their hyperphalangism, heart defect, short stature, and developmental delay. We suggest performance of urine organic acid analysis in patients with suspected Catel-Manzke syndrome, particularly in those with cardiac or vertebral defects or without mutations in TGDS.
ScienceDirect (2020)
CLICK HERE TO READ THE ARTICLE
